HOME ABOUT US PRINT PUBLICATIONS SUBSCRIPTIONS CONTACT US TELL FRIEND RSS

Welcome to FDAweb Pay Per View Search our 45,601 - story database FREE   Free Items  Warning Letters  FDA Notices  FDA Calendar    FDA Whistleblowers          << Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 Next >>   Fenwal Recalls Anticoagulant Due to Labeling Mishap [92 Words] [ Price : $7.95] Fenwal recalls one lot of its Anticoagulant Citrate Phosphate Dextrose Solution, USP Blood-Pack Unit due to labeling mishap. 05/02/2013     Supplier Wants OxyContin Impurity Limit Retained [176 Words] [ Price : $7.95] Rhodes Technologies says FDA should not relax the current limit of 10 ppm on 14-hydroxycodeinone in oxycodone API. 05/02/2013     Vicerex, Black Ant Supplements Recalled Due to ED Drugs [131 Words] [ Price : $7.95] American Lifestyle recalls all lots of Vicerex and Black Ant capsules due to undeclared ingredients found in prescription erectile dysfunction drugs. 05/02/2013     New Mobile App Regulatory Environment Needed: Expert [228 Words] [ Price : $7.95] Speakers at a Politico health tech conference say more and stricter government regulation of mobile medical apps is needed. 05/02/2013     Panel Votes Down Aveo’s Tivozanib [176 Words] [ Price : $7.95] Aveo Oncology fails to gain the backing of FDA’s Oncologic Drugs Advisory Committee that reviewed an NDA for tivozanib. 05/02/2013     Salix Wants Apriso Bioequivalence Criteria Imposed [338 Words] [ Price : $7.95] Salix asks FDA not to approve any ANDA referencing its Apriso that doesn’t demonstrate bioequivalence through means requested by the company. 05/02/2013     FDA Clears PlasmaJet for Removing Soft Tissue [83 Words] [ Price : $7.95] FDA grants 510(k) clearance to Plasma Surgical for the PlasmaJet to remove soft tissue by vaporization. 05/01/2013     FDA Releases Novartis Consumer Health Inspection Report [296 Words] [ Price : $7.95] FDA releases an FDA-483 detailing inspection findings, including many repeat observations, from the latest inspection at the troubled Novartis Consumer Health drug manufacturing facility in Lincoln, NE. 05/01/2013     FDA Releases New and Updated Safety Signal Reports [89 Words] [ Price : $7.95] FDA releases new and updated quarterly reports on safety signals identified in drug products. 05/01/2013     Forest, Almirall Plan NDA for COPD Drug in 4th Quarter [228 Words] [ Price : $7.95] Forest Laboratories and Almirall plan an NDA submission in the fourth quarter for their investigational chronic obstructive pulmonary disease combination drug Pressair (aclidinium bromide and formoterol fumarate). 05/01/2013     << Prev  1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20  Next >>

FERDIC INCORPORATED - P.O. Box 28, Camp Hill, PA 17001 | Phone: (717)731-1426 fax:(717)731-1427 Email: info@fdaweb.com